DOI:
10.1055/s-00000140
Pädiatrie up2date
LinksClose Window
References
Buderus S, Boone J, Lyerly D et al.
Fecal Laktoferrin: A new parameter to monitor infliximab therapy.
Dig Dis Sci 2004;
49: 1036-1039
We do not assume any responsibility for the contents of the web pages of other providers.